Skip to main content

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company

The company also said on Thursday its CEO resigned. Shares were down 47% in pre-market trading.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.